- Bottle
- 15 mL at 150 mg/mL; stated total 2,250 mg
- Promotion
- DW20 first-order offer; confirm exact checkout amount
- Named inclusions
- Bottle, expedited shipping, consultation and ongoing doctor care
A bottle with a published specification
Good Life Meds lists its NAD+ nasal spray as 15 mL at 150 mg/mL, with a stated total of 2,250 mg. Those figures identify the advertised bottle more precisely than a generic starting price. They do not establish how much reaches the bloodstream or another tissue, and they should not be used to infer equivalence to an injection or IV service.
The product page describes a compounded preparation supplied through a pharmacy when prescribed. The clinician and pharmacy should confirm the actual bottle and instructions for the individual order. We have not obtained a prescription, examined the dispensed label or independently tested the formula's concentration, stability or delivery performance.
Two prices describe different purchase conditions
The nasal page displays $139 as the list figure and $111 as a promotional headline. The lower offer is tied to a first order and the DW20 code. Those conditions matter: the headline does not demonstrate that every subsequent bottle will cost $111 or that the amount covers one calendar month for every patient.
Confirm the exact checkout total, since a percentage promotion and a rounded dollar headline may not produce identical arithmetic at every stage. Ask about automatic renewal, supply period and the terms for another bottle. A price per package is useful information, but a continuing care budget needs the actual payment and refill schedule as well.
The included services are more explicit here
The page lists the 15 mL bottle, expedited shipping, a doctor consultation and ongoing doctor care among the inclusions. That gives a clearer starting point than an unexplained bottle-only price. It still does not establish the cost of every possible laboratory assessment or the response time for a specific clinical question.
Ask which team handles medical concerns and which handles shipment problems. Obtain pharmacy-specific storage and beyond-use instructions and clarify the process if delivery conditions are not met. An expedited-shipping claim cannot establish how long the preparation remains usable after opening or whether exposure outside its required conditions is acceptable.
Do not turn route claims into proven outcomes
Good Life Meds markets nasal NAD+ around mental clarity, energy and aging-related goals, including language about delivery near the brain. We did not independently verify those clinical claims for the finished product. A route description or biological mechanism is not proof of a predictable improvement, and experiences with other products on the site are not evidence for this bottle.
Discuss the proposed purpose and supporting human evidence with the clinician. FDA does not approve compounded preparations, so pharmacy oversight should remain separate from product approval claims. This review adds a documented bottle size, concentration and first-order promotion to the comparison. The remaining decision depends on the actual prescription, complete charge and renewal terms, together with realistic expectations about what the available evidence establishes.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.